Clinicopathological Predictors of Survival for Parotid Mucoepidermoid Carcinoma: A Systematic Review.
mucoepidermoid carcinoma
parotid gland
prognostic factors
Journal
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
received:
10
12
2021
accepted:
22
02
2022
medline:
28
3
2023
pubmed:
23
3
2022
entrez:
22
3
2022
Statut:
ppublish
Résumé
Various prognostic factors are associated with the survival of patients with parotid mucoepidermoid carcinoma (MEC). The aim of this systematic review is to summarize the clinical and pathologic prognostic factors on survival outcomes in patients with parotid MEC. Articles published from database inception to July 2020 on OVID Medline, OVID Embase, Cochrane Central, and Scopus. Studies were included that reported clinical or pathologic prognostic factors on survival outcomes for adult patients with parotid MEC. Data extraction, risk of bias, and quality assessment were conducted by 2 independent reviewers. A total of 4290 titles were reviewed, 396 retrieved for full-text screening, and 18 included in the review. The average risk of bias was high, and quality assessment for the prognostic factors ranged from very low to moderate. Prognostic factors that were consistently associated with negative survival outcomes on multivariate analysis included histologic grade (hazard ratio [HR], 5.66), nodal status (HR, 2.86), distant metastasis (HR, 3.10-5.80), intraparotid metastasis (HR, 13.52), and age (HR, 1.02-6.86). Prognostic factors that inconsistently reported associations with survival outcomes were TNM stage, T classification, and N classification. Histologic grade, nodal status, distant metastasis, intraparotid metastasis, and age were associated with worse survival outcomes. These prognostic factors should be considered when determining the most appropriate treatment and follow-up plan for patients with parotid MEC.
Identifiants
pubmed: 35316125
doi: 10.1177/01945998221086845
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
611-618Informations de copyright
© 2022 The Authors. Otolaryngology-Head and Neck Surgery published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngology-Head and Neck Surgery Foundation.
Références
Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120(6):834-840. doi:10.1016/s0194-5998(99)70323-2
Ettl T, Schwarz-Furlan S, Gosau M, Reichert TE. Salivary gland carcinomas. Oral Maxillofac Surg. 2012;16(3):267-283. doi:10.1007/s10006-012-0350-9
Brandwein MS, Ivanov K, Wallace DI, et al.Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25(7):835-845. doi:10.1097/00000478-200107000-00001
Evans HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol. 1984;81(6):696-701. doi:10.1093/ajcp/81.6.696
Ho K, Lin H, Ann DK, Chu PG, Yen Y. An overview of the rare parotid gland cancer. Head Neck Oncol. 2011;3:40. doi:10.1186/1758-3284-3-40
Seethala RR, Stenman G. Update from the 4th edition of the World Health Organization classification of head and neck tumours: tumors of the salivary gland. Head Neck Pathol. 2017;11(1):55-67. doi:10.1007/s12105-017-0795-0
To VSH, Chan JYW, Tsang RKY, Wei WI. Review of salivary gland neoplasms. ISRN Otolaryngol. 2012;2012:872982.
Agulnik M, McGann CF, Mittal BB, Gordon SC, Epstein JB. Management of salivary gland malignancies: current and developing therapies. Oncol Rev. 2008;2(2):86-94. doi:10.4081/oncol.2008.114
Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990;116(3):290-293. doi:10.1001/archotol.1990.01870030054008
Chen AM, Lau VH, Farwell DG, Luu Q, Donald PJ. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome. Laryngoscope. 2013;123(12):3049-3055. doi:10.1002/lary.24238
Chen MM, Roman SA, Sosa JA, Judson BL. Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients. Head Neck. 2014;36(2):158-163. doi:10.1002/hed.23256
Shang X, Fang Q, Liu F, Wu J, Luo R, Qi J. Deep parotid lymph node metastasis is associated with recurrence in high-grade mucoepidermoid carcinoma of the parotid gland. J Oral Maxillofac Surg. 2019;77(7):1505-1509. doi:10.1016/j.joms.2019.01.031
Rajasekaran K, Stubbs V, Chen J, et al.Mucoepidermoid carcinoma of the parotid gland: a National Cancer Database study. Am J Otolaryngol. 2018;39(3):321-326. doi:10.1016/j.amjoto.2018.03.022
Bosma SE, Ayu O, Fiocco M, Gelderblom H, Dijkstra PDS. Prognostic factors for survival in Ewing sarcoma: a systematic review. Surg Oncol. 2018;27(4):603-610. doi:10.1016/j.suronc.2018.07.016
Krzyszczyk P, Acevedo A, Davidoff EJ, et al.The growing role of precision and personalized medicine for cancer treatment. Technology. 2018;6(3-4):79-100. doi:10.1142/S2339547818300020
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280-286. doi:10.7326/0003-4819-158-4-201302190-00009.
Hayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144(6):427-437. doi:10.7326/0003-4819-144-6-200603210-00010
Bakker SH, Jacobs WCH, Pondaag W, et al.Chordoma: a systematic review of the epidemiology and clinical prognostic factors predicting progression-free and overall survival. Eur Spine J. 2018;27(12):3043-3058. doi:10.1007/s00586-018-5764-0
Ubachs J, Ziemons J, Minis-Rutten IJG, et al.Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(6):1165-1174. doi:10.1002/jcsm.12468
Totten AM, Cheney TP, O'Neil ME, et al.Risk of bias criteria. In: Physiologic Predictors of Severe Injury: Systematic Review. Agency for Healthcare Research and Quality; 2018.
Huguet A, Hayden JA, Stinson J, et al.Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Syst Rev. 2013;2(1):1-12. doi:10.1186/2046-4053-2-71
Siemieniuk R, Guyatt G. What is GRADE? Accessed April 4, 2021. https://bestpractice.bmj.com/info/toolkit/learn-ebm/what-is-grade/
Bhattacharyya N, Fried MP. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol. 2005;26(1):39-44. doi:10.1016/j.amjoto.2004.06.017
Sun J, Sun Y, Yang F, et al.Nomogram to predict the prognosis of parotid gland mucoepidermoid carcinoma: a population-based study of 1306 cases. PeerJ. 2019;7:e7237. doi:10.7717/peerj.7237
Morse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: institutional variation and survival association. Laryngoscope. 2019;129(1):129-137. doi:10.1002/lary.27221
Xiao CC, Zhan KY, White-Gilbertson SJ, Day TA. Predictors of nodal metastasis in parotid malignancies: a National Cancer Data Base study of 22,653 patients. Otolaryngol Head Neck Surg. 2016;154(1):121-130. doi:10.1177/0194599815607449
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276-282.
Vickers AJ, Bianco FJ, Cronin AM, et al.The learning curve for surgical margins after open radical prostatectomy: implications for the use of margin status as an oncologic endpoint. J Urol. 2010;183(4):1360-1365. doi:10.1016/j.juro.2009.12.015
Shirah GR, Hsu CH, Heberer MA, et al.Teaching residents may affect the margin status of breast-conserving operations. Surg Today. 2015;46(4):437-444. doi:10.1007/s00595-015-1184-5
Wu ZY, Wu WJ, Zheng L, et al.Efficacy of combined surgery and I seed brachytherapy for treatment of primary mucoepidermoid carcinoma of the parotid gland. Head Neck. 2019;41(9):3219-3225. doi:10.1002/hed.25813
Wu J, Fang Q, Liu F, Zhang X. Intraparotid node metastases in adults with parotid mucoepidermoid cancer: an indicator of prognosis? Br J Oral Maxillofac Surg. 2020;58(5):525-529. doi:10.1016/j.bjoms.2019.10.323
Theriault C, Fitzpatrick PJ. Malignant parotid tumors: prognostic factors and optimum treatment. Am J Clin Oncol. 1986;9(6):510-516. doi:10.1097/00000421-198612000-00009
Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82(7):1217-1224. doi:10.1002/(sici)1097-0142(19980401) 82:7<1217::aid-cncr2>3.0.co;2-c
Ghosh-Laskar S, Murthy V, Wadasadawala T, et al.Mucoepidermoid carcinoma of the parotid gland: factors affecting outcome. Head Neck. 2011;33(4):497-503. doi:10.1002/hed.21477
Rapidis AD, Givalos N, Gakiopoulou H, et al.Mucoepidermoid carcinoma of the salivary glands: review of the literature and clinicopathological analysis of 18 patients. Oral Oncol. 2007;43(2):130-136. doi:10.1016/j.oraloncology.2006.03.001
Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies: a clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307-315. doi:10.1001/archotol.1991.01870150075010
Niu X, Fang Q, Liu F. Role of intraparotid node metastasis in mucoepidermoid carcinoma of the parotid gland. BMC Cancer. 2019;19(1):417. doi:10.1186/s12885-019-5637-x
Jakobsson PA, Blanck C, Eneroth CM. Mucoepidermoid carcinoma of the parotid gland. Cancer. 1968;22(1):111-124. doi:10.1002/1097-0142(196807)22:1<111::aid-cncr2820220114>3.0.co;2-j
Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies: a clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307-315. doi:10.1001/archotol.1991.01870150075010
Lim CM, Gilbert MR, Johnson JT, Kim S. Clinical significance of intraparotid lymph node metastasis in primary parotid cancer. Head Neck. 2014;36(11):1634-1637. doi:10.1002/hed.23507
Shaha JP, Monterob PH. New AJCC/UICC staging system for head and neck, and thyroid cancer. Revista Médica Clínica Las Condes. 2018;29(4):397-404. doi:10.1016/j.rmclc.2018.07.002
Wahlberg P, Anderson H, Biörklund A, Möller T, Perfekt R. Carcinoma of the parotid and submandibular glands-a study of survival in 2465 patients. Oral Oncol. 2002;38(7):706-713. doi:10.1016/s1368-8375(02)00007-6
McHugh CH, Roberts DB, El-Naggar AK, et al.Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118(16):3928-3936. doi:10.1002/cncr.26697
Hicks MJ, el-Naggar AK, Byers RM, Flaitz CM, Luna MA, Batsakis JG. Prognostic factors in mucoepidermoid carcinomas of major salivary glands: a clinicopathologic and flow cytometric study. Eur J Cancer B Oral Oncol. 1994;30B(5):329-334. doi:10.1016/0964-1955(94)90034-5
Pires FR, de Almeida OP, de Araújo VC, Kowalski LP. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130(2):174-180. doi:10.1001/archotol.130.2.174
Stewart FW, Foote FW, Becker WF. Muco-epidermoid tumors of salivary glands. Ann Surg. 1945;122(5):820-844. doi:10.1097/00000658-194511000-00005
Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3(1):69-77. doi:10.1007/s12105-009-0102-9
Micheli A, Mariotto A, Giorgi RA, Gatta G, Muti P; EUROCARE Working Group. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer. 1998;34(14):2271-2278. doi:10.1016/s0959-8049(98)00324-4
Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171(1):151-158. doi:10.1016/j.jss.2009.11.721
Cleary PD, Mechanic D, Greenley JR. Sex differences in medical care utilization: an empirical investigation. J Health Soc Behav. 1982;23(2):106-119.
Gove WR, Hughes M. Possible causes of the apparent sex differences in physical health: an empirical investigation. Am Sociol Rev. 1979;44(1):126-146.
Wallen J, Waitzkin H, Stoeckle JD. Physician stereotypes about female health and illness: a study of patient's sex and the informative process during medical interviews. Women Health. 1979;4(2):135-146. doi:10.1300/J013v04n02_03
Adami HO. The effect of female sex hormones on cancer survival. JAMA. 1990;263(16):2189-2193. doi:10.1001/jama.1990.03440160051036
Waldron I. Sex differences in illness incidence, prognosis and mortality: issues and evidence. Soc Sci Med. 1983;17(16):1107-1123. doi:10.1016/0277-9536(83)90004-7